Defining the possible therapeutic benefit of lymphadenectomy among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma

Journal of Surgical Oncology

Volumn 113, Issue 6, 2016, Pages 685-691

  Vitale, Alessandro ^a   Moustafa, Mohamed ^a   Spolverato, Gaya ^b   Gani, Faiz ^b   Cillo, Umberto ^a   Pawlik, Timothy M ^b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

intrahepatic cholangiocarcinoma; liver surgery; lymphadenectomy; survival

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER PROGNOSIS; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LIVER RESECTION; LONG TERM SURVIVAL; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; SEX; SURVIVAL RATE; BILE DUCT NEOPLASMS; CANCER REGISTRY; CHOLANGIOCARCINOMA; FOLLOW UP; INTRAHEPATIC BILE DUCT; MIDDLE AGED; MORTALITY; PROPENSITY SCORE; RETROSPECTIVE STUDY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; PROPENSITY SCORE; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84959574032     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.24213     Document Type: Article

References (47)

1. Bridgewater J, Galle PR, Khan SA, et al.,: Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 2014; 60: 1268-1289.
2. Amini N, Ejaz A, Spolverato G, et al.,: Management of lymph nodes during resection of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A systematic review. J Gastrointest Surg 2014; 18: 2136-2148.
3. Aljiffry M, Abdulelah A, Walsh M, et al.,: Evidence-based approach to cholangiocarcinoma: A systematic review of the current literature. J Am Coll Surg 2009; 208: 134-147.
4. Jiang L, Yang KH, Guan QL, et al.,: Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: A meta-Analysis. J Surg Oncol 2013; 107: 807-814.
5. Shaib Y, El-Serag HB,: The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004; 24: 115-125.
6. Shaib YH, Davila JA, McGlynn K, et al.,: Rising incidence of intrahepatic cholangiocarcinoma in the United States: A true increase ? J Hepatol 2004; 40: 472-477.
7. Spolverato G, Yakoob MY, Kim Y, et al.,: Impact of complications on long-term survival after resection of intrahepatic cholangiocarcinoma. Cancer 2015; 121: 2730-2739.
8. Spolverato G, Kim Y, Ejaz A, et al.,: Conditional probability of long-term survival after liver resection for intrahepatic cholangiocarcinoma: A multi-institutional analysis of 535 patients. JAMA Surg 2015; 150: 538-545.
9. Park J, Kim MH, Kim KP, et al.,: Natural history and prognostic factors of advanced cholangiocarcinoma without surgery, chemotherapy, or radiotherapy: A large-scale observational study. Gut Liver 2009; 3: 298-305.
10. Nathan H, Aloia TA, Vauthey JN, et al.,: A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 2009; 16: 14-22.
11. Nakagawa T, Kamiyama T, Kurauchi N, et al.,: Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg 2005; 29: 728-733.
12. Amini N, Spolverato G, Kim Y, et al.,: Lymph node status after resection for gallbladder adenocarcinoma: Prognostic implications of different nodal staging/scoring systems. J Surg Oncol 2015; 111: 299-305.
13. Kim DH, Choi DW, Choi SH, et al.,: Is there a role for systematic hepatic pedicle lymphadenectomy in intrahepatic cholangiocarcinoma? A review of 17 years of experience in a tertiary institution. Surgery 2015; 157: 666-675.
14. Morine Y, Shimada M,: The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics. J Gastroenterol 2015; 50: 913-927.
15. Shimada K, Sano T, Nara S, et al.,: Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. Surgery 2009; 145: 411-416.
16. de Jong MC, Nathan H, Sotiropoulos GC, et al.,: Intrahepatic cholangiocarcinoma: An international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 2011; 29: 3140-3145.
17. Parsons HM, Tuttle TM, Kuntz KM, et al.,: Association between lymph node evaluation for colon cancer and node positivity over the past 20 years. JAMA 2011; 306: 1089-1097.
18. Li DY, Zhang HB, Yang N, et al.,: Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: Results of a monocentric series. World J Gastroenterol 2013; 19: 9084-9091.
19. Guglielmi A, Ruzzenente A, Campagnaro T, et al.,: Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma. J Gastrointest Surg 2013; 17: 1917-1928.
20. Gleisner AL, Spolverato G, Ejaz A, et al.,: Time-related changes in the prognostic significance of the total number of examined lymph nodes in node-negative pancreatic head cancer. J Surg Oncol 2014; 110: 858-863.
21. Clark CJ, Wood-Wentz CM, Reid-Lombardo KM, et al.,: Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: A population-based study using the National Cancer Institute SEER database. HPB (Oxford) 2011; 13: 612-620.
22. Wang Y, Li J, Xia Y, et al.,: Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol 2013; 31: 1188-1195.
23. Hyder O, Marques H, Pulitano C, et al.,: A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: An Eastern and Western experience. JAMA Surg 2014; 149: 432-438.
24. Mavros MN, Economopoulos KP, Alexiou VG, et al.,: Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: Systematic review and meta-Analysis. JAMA Surg 2014; 149: 565-574.
25. Vitale A, Burra P, Frigo AC, et al.,: Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study. J Hepatol 2015; 62: 617-624.
26. Burnand B, Kernan WN, Feinstein AR,: Indexes and boundaries for "quantitative significance" in statistical decisions. J Clin Epidemiol 1990; 43: 1273-1284.
27. Choi SB, Kim KS, Choi JY, et al.,: The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: Association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol 2009; 16: 3048-3056.
28. Spolverato G, Yakoob MY, Kim Y, et al.,: The impact of surgical margin status on long-term outcome after resection for intrahepatic cholangiocarcinoma. Ann Surg Oncol 2015; 22: 4020-4028.
29. Spolverato G, Vitale A, Cucchetti A, et al.,: Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma ? Cancer 2015; 121: 3998-4006.
30. Morine Y, Shimada M, Utsunomiya T, et al.,: Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma. Surg Today 2012; 42: 147-151.
31. Miwa S, Miyagawa S, Kobayashi A, et al.,: Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. J Gastroenterol 2006; 41: 893-900.
32. Shimada M, Yamashita Y, Aishima S, et al.,: Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg 2001; 88: 1463-1466.
33. Ercolani G, Grazi GL, Ravaioli M, et al.,: The role of lymphadenectomy for liver tumors: Further considerations on the appropriateness of treatment strategy. Ann Surg 2004; 239: 202-209.
34. Kobayashi S, Takahashi S, Kato Y, et al.,: Surgical treatment of lymph node metastases from hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 2011; 18: 559-566.
35. Kim Y, Spolverato G, Amini N, et al.,: Surgical management of intrahepatic cholangiocarcinoma: Defining an optimal prognostic lymph node stratification schema. Ann Surg Oncol 2015; 22: 2772-2778.
36. Bagante F, Gani F, Spolverato G, et al.,: Intrahepatic cholangiocarcinoma: Prognosis of patients who did not undergo lymphadenectomy. J Am Coll Surg 2015; 221: 1031-1040.
37. Sakuramoto S, Kikuchi S, Futawatari N, et al.,: Laparoscopy-Assisted pancreas- and spleen-preserving total gastrectomy for gastric cancer as compared with open total gastrectomy. Surg Endosc 2009; 23: 2416-2423.
38. Songun I, Putter H, Kranenbarg EM, et al.,: Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010; 11: 439-449.
39. Spolverato G, Ejaz A, Kim Y, et al.,: Prognostic performance of different lymph node staging systems after curative intent resection for gastric adenocarcinoma. Ann Surg 2015; 262: 991-998.
40. Gleisner AL, Mogal H, Dodson R, et al.,: Nodal status, number of lymph nodes examined, and lymph node ratio: what defines prognosis after resection of colon adenocarcinoma ? J Am Coll Surg 2013; 217: 1090-1100.
41. Asiyanbola B, Gleisner A, Herman JM, et al.,: Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-flurouracil-based chemoradiation therapy: Effect of number of metastatic lymph nodes and lymph node ratio. J Gastrointest Surg 2009; 13: 752-759.
42. Slidell MB, Chang DC, Cameron JL, et al.,: Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: A large, population-based analysis. Ann Surg Oncol 2008; 15: 165-174.
43. Spolverato G, Kim Y, Alexandrescu S, et al.,: Is hepatic resection for large or multifocal intrahepatic cholangiocarcinoma justified? Results from a multi-institutional collaboration. Ann Surg Oncol 2015; 22: 2218-2225.
44. Nathan H, Pawlik TM,: Limitations of claims and registry data in surgical oncology research. Ann Surg Oncol 2008; 15: 415-423.
45. Gleisner AL, Choti MA, Assumpcao L, et al.,: Colorectal liver metastases: Recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation. Arch Surg 2008; 143: 1204-1212.
46. Mayo SC, de Jong MC, Bloomston M, et al.,: Surgery versus intra-Arterial therapy for neuroendocrine liver metastasis: A multicenter international analysis. Ann Surg Oncol 2011; 18: 3657-3665.
47. Vitale A, Morales RR, Zanus G, et al.,: Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: A multicentre, cohort study. Lancet Oncol 2011; 12: 654-662.